C-Ray Therapeutics
PrivateLast Round
Series A
Extension
Nov 16, 2024
Total Funding Raised
$100M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
C-Ray Therapeutics operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series A Extension round in November 2024.
C-Ray Therapeutics is a biopharmaceutical company that provides end-to-end radiopharmaceutical development and manufacturing services, including preclinical evaluation, clinical supply, and commercial-scale cGMP production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
C-Ray Therapeutics Comparables
Compare C-Ray Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaGen Therapeutics | 92% | |
| Bivision Pharma | 87% | |
| Boomray Pharmaceuticals Co., Ltd. | 85% |
For institutional investors. Book with your work email.
C-Ray Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 16, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Grew 43% QoQ from 7 to 10 employees.
- Nov 16, 2024
$100M round with participation from 3SBio Inc.
For institutional investors. Book with your work email.
C-Ray Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about C-Ray Therapeutics's valuation, stock price, and market status.
Is C-Ray Therapeutics a public or private company?
C-Ray Therapeutics is a private company.
What is the current stock price of C-Ray Therapeutics?
C-Ray Therapeutics is a private company, so its shares have no public market price. Caplight tracks C-Ray Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is C-Ray Therapeutics worth (valuation)?
Valuation information for C-Ray Therapeutics is not publicly available.
Can I buy C-Ray Therapeutics stock?
C-Ray Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was C-Ray Therapeutics's last funding round?
C-Ray Therapeutics's most recent funding round was Series A Extension on November 16, 2024.
Who are the main investors in C-Ray Therapeutics?
Investor information for C-Ray Therapeutics is not publicly disclosed.
Will C-Ray Therapeutics IPO soon?
No public IPO plans have been announced for C-Ray Therapeutics.
How can I track C-Ray Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in C-Ray Therapeutics's shares on secondary markets.